Your browser doesn't support javascript.
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection.
Chodick, Gabriel; Nutman, Amir; Yiekutiel, Naama; Shalev, Varda.
  • Chodick G; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Nutman A; Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, 27 Hamered Street, Tel Aviv, 68125 Israel.
  • Yiekutiel N; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shalev V; National Center for Infection Control and Antibiotic Resistance, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
J Travel Med ; 27(5)2020 Aug 20.
Article in English | MEDLINE | ID: covidwho-1387938

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Angiotensin Receptor Antagonists Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal subject: Communicable Diseases / Public Health Year: 2020 Document Type: Article Affiliation country: JTM

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Angiotensin Receptor Antagonists Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal subject: Communicable Diseases / Public Health Year: 2020 Document Type: Article Affiliation country: JTM